Your browser doesn't support javascript.
loading
Based on ARASENS trial: efficacy and safety of darolutamide as an emerging option of endocrinotherapy for metastatic hormone-sensitive prostate cancer-an updated systematic review and network meta-analysis.
Dou, Maoyang; Liang, Hao; Liu, Yang; Zhang, Qiujie; Li, Ruowen; Chen, Shouzhen; Shi, Benkang.
Afiliação
  • Dou M; Department of Urology, Qilu Hospital of Shandong University, Jinan City, Shandong Province, China.
  • Liang H; Department of Urology, Qilu Hospital of Shandong University, Jinan City, Shandong Province, China.
  • Liu Y; Department of Urology, Qilu Hospital of Shandong University, Jinan City, Shandong Province, China.
  • Zhang Q; Department of Urology, Weifang People's Hospital, Weifang Medical University, Weifang, Shandong, China.
  • Li R; Department of Health Care, Qilu Hospital of Shandong University, Jinan City, Shandong Province, China.
  • Chen S; Department of Hernia and Abdominal Wall Surgery, Qilu Hospital of Shandong University, Jinan City, Shandong Province, China.
  • Shi B; Department of Urology, Qilu Hospital of Shandong University, Jinan City, Shandong Province, China. chenshouzhen1990@163.com.
J Cancer Res Clin Oncol ; 149(10): 7017-7027, 2023 Aug.
Article em En | MEDLINE | ID: mdl-36856851

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Receptores Androgênicos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans / Male Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Receptores Androgênicos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans / Male Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China